Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis.

Aronsson M, Svennberg E, Rosenqvist M, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Levin LÅ.

Europace. 2017 Mar 1. doi: 10.1093/europace/eux002. [Epub ahead of print]

PMID:
28340009
2.

N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.

Svennberg E, Henriksson P, Engdahl J, Hijazi Z, Al-Khalili F, Friberg L, Frykman V.

Heart. 2017 Mar 2. pii: heartjnl-2016-310236. doi: 10.1136/heartjnl-2016-310236. [Epub ahead of print]

PMID:
28255099
3.

Defibrillation before EMS arrival in western Sweden.

Claesson A, Herlitz J, Svensson L, Ottosson L, Bergfeldt L, Engdahl J, Ericson C, Sandén P, Axelsson C, Bremer A.

Am J Emerg Med. 2017 Feb 16. pii: S0735-6757(17)30117-1. doi: 10.1016/j.ajem.2017.02.030. [Epub ahead of print]

PMID:
28238537
4.

Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design.

Engdahl J, Svennberg E, Friberg L, Al-Khalili F, Frykman V, Kemp Gudmundsdottir K, Fredriksson T, Rosenqvist M.

Europace. 2017 Feb 1;19(2):297-302. doi: 10.1093/europace/euw319.

PMID:
28011798
5.

Why should we screen for atrial fibrillation?

Svennberg E, Engdahl J.

Heart. 2017 Jan 1;103(1):6-7. doi: 10.1136/heartjnl-2016-310305. Epub 2016 Oct 12. No abstract available.

PMID:
27733534
6.

Drug therapy in cardiac arrest: a review of the literature.

Lundin A, Djärv T, Engdahl J, Hollenberg J, Nordberg P, Ravn-Fischer A, Ringh M, Rysz S, Svensson L, Herlitz J, Lundgren P.

Eur Heart J Cardiovasc Pharmacother. 2016 Jan;2(1):54-75. doi: 10.1093/ehjcvp/pvv047. Epub 2015 Nov 26. Review.

PMID:
27533062
7.

Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.

Engdahl J, Holmén A, Svennberg E, Friberg L, Frykman-Kull V, Al-Khalili F, Rosenqvist M, Strömberg U.

Int J Cardiol. 2016 Nov 1;222:430-5. doi: 10.1016/j.ijcard.2016.07.198. Epub 2016 Jul 29.

PMID:
27505329
8.

Detection of Atrial Fibrillation with Intermittent Handheld Electrocardiogram in Patients with Ischemic Stroke and Transient Ischemic Attack.

Olsson AS, Engdahl J.

J Stroke Cerebrovasc Dis. 2016 Nov;25(11):2648-2652. doi: 10.1016/j.jstrokecerebrovasdis.2016.07.010. Epub 2016 Aug 1.

PMID:
27492946
9.

Campylobacter jejuni-associated perimyocarditis: two case reports and review of the literature.

Hessulf F, Ljungberg J, Johansson PA, Lindgren M, Engdahl J.

BMC Infect Dis. 2016 Jun 14;16:289. doi: 10.1186/s12879-016-1635-7.

10.

Echocardiographic measures of atrial function may predict atrial fibrillation in stroke patients.

Waldenhjort D, Sobocinski Doliwa P, Alam M, Frykman-Kull V, Engdahl J, Rosenqvist M, Persson H.

Scand Cardiovasc J. 2016 Aug;50(4):236-42. doi: 10.1080/14017431.2016.1175657. Epub 2016 May 18.

PMID:
27192631
11.

Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillation.

Svennberg E, Stridh M, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M.

Europace. 2016 Oct 6. doi: 10.1093/europace/euw286. [Epub ahead of print]

PMID:
28339578
12.

[Looking for atrial fibrillation--several reasons for screening].

Svennberg E, Engdahl J.

Lakartidningen. 2015 Sep 8;112. pii: DHSI. Review. Swedish.

PMID:
26348043
13.

Low rate of and rapid attention to inappropriate ICD shocks with remote device and rhythm monitoring: a qualitative study.

Sandgren E, Rorsman C, Engdahl J, Edvardsson N.

Open Heart. 2015 Jul 27;2(1):e000249. doi: 10.1136/openhrt-2015-000249. eCollection 2015.

14.

Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism?

Johansson AK, Juhlin T, Engdahl J, Lind S, Hagwall K, Rorsman C, Fodor E, Alenholt A, Paul Nordin A, Rosenqvist M, Frick M.

Europace. 2015 Oct;17(10):1514-7. doi: 10.1093/europace/euv123. Epub 2015 May 27.

PMID:
26017466
15.

Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study.

Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M.

Circulation. 2015 Jun 23;131(25):2176-84. doi: 10.1161/CIRCULATIONAHA.114.014343. Epub 2015 Apr 24.

16.

Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording.

Aronsson M, Svennberg E, Rosenqvist M, Engdahl J, Al-Khalili F, Friberg L, Frykman-Kull V, Levin LÅ.

Europace. 2015 Jul;17(7):1023-9. doi: 10.1093/europace/euv083. Epub 2015 Apr 12.

PMID:
25868469
17.

[Uncertain if drugs do any good after cardiac arrest].

Engdahl J, Hollenberg J, Rubertsson S, Holmgren C, Rosenqvist M.

Lakartidningen. 2015 Mar 30;112. pii: CZ4R. Review. Swedish. No abstract available.

PMID:
25825901
18.

[More and more defibrillators in the community--but few used].

Hollenberg J, Ringh M, Fredman D, Claesson A, Engdahl J.

Lakartidningen. 2015 Mar 31;112. pii: C7E6. Review. Swedish. No abstract available.

PMID:
25825882
19.

Uptake of atrial fibrillation screening aiming at stroke prevention: geo-mapping of target population and non-participation.

Engdahl J, Holmén A, Rosenqvist M, Strömberg U.

BMC Public Health. 2013 Aug 3;13:715. doi: 10.1186/1471-2458-13-715.

20.

Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention.

Engdahl J, Andersson L, Mirskaya M, Rosenqvist M.

Circulation. 2013 Feb 26;127(8):930-7. doi: 10.1161/CIRCULATIONAHA.112.126656. Epub 2013 Jan 23.

Supplemental Content

Loading ...
Support Center